Nancy Palnik
Psychiatric/Mental Health · Columbus, OHNPI 1124360607
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 322 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,923, 5.2 times the $371 reported in 2021. Among psychiatric/mental health clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 322 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$920
- AbbVie$876
- Axsome Therapeutics, Inc.$856
- Teva Pharmaceuticals USA, Inc.$800
- Alkermes, Inc.$759
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$622
- plus $2K from 14 others
What the payments were for
- Food & beverage$6,53999%
- Education$871%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 42 | $920 |
| AbbVie | 65 | $876 |
| Axsome Therapeutics, Inc. | 31 | $856 |
| Teva Pharmaceuticals USA, Inc. | 37 | $800 |
| Alkermes, Inc. | 38 | $759 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 22 | $622 |
| Neurocrine Biosciences, Inc. | 25 | $564 |
| Lundbeck LLC | 24 | $379 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $228 |
| Johnson & Johnson | 6 | $166 |
| Tris Pharma Inc | 4 | $153 |
| Vanda Pharmaceuticals Inc. | 3 | $62 |
| Sunovion Pharmaceuticals Inc. | 3 | $56 |
| Supernus Pharmaceuticals, Inc. | 2 | $43 |
| Bausch Health US, LLC | 3 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| Noven Pharmaceuticals, Inc. | 1 | $22 |
| Corium, LLC | 1 | $17 |
| Almatica Pharma LLC | 1 | $15 |
| Noven Therapeutics, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$230
- CAPLYTA$224
- REXULTI$108
- SPRAVATO$108
- VRAYLAR$103
- Quillichew ER$102
- Dyanavel XR$102
- Quillivant$102
How this compares
$6,627 in reported general payments places this provider in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 31 | $14,882 |
| Aripiprazole | 11 | $3,285 |
| Buspirone Hcl | 54 | $520 |
| Sertraline Hcl | 42 | $477 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 15 | $449 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 24 | $334 |
| Lurasidone Hcl | 19 | $308 |
| Hydroxyzine Pamoate | 14 | $210 |
| Zolpidem Tartrate | 14 | $126 |
| Lamotrigine | 19 | $93 |
| Gabapentin | 12 | $79 |
| Clonazepam | 25 | $74 |
| Lorazepam | 38 | $70 |
| Risperidone | 13 | $59 |
| Trazodone Hcl | 22 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $228 | $14,88231 claims |
| Almatica Pharma LLCSertraline Hcl | $15 | $47742 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.
Other psychiatric/mental health in Columbus
- Holly SchweitzerColumbus$78K
- David HuffmanColumbus$50K
- Tarsicio GacheruColumbus$18K
- Alicja MatusiakColumbus$11K
- Summer LawsonColumbus$11K
- Gregory BlankenshipColumbus$10K
- Jennifer WilsonColumbus$10K
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.